Insider acquisitions

Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.

Reset
Form 4, 4/A, 5 & 5/AAmounts retain the reported currency, when available.

Transaction timeline & trade size

Choose a reporting owner, transaction period, and security. Open any point for the filing.

Purchases in this page37
Other acquisitions13
Reporting owners24
SalesNot providedCheck original SEC filings

Dec 16, 2025 – Dec 18, 2025 · Transaction dates · Current page sample

Reported quantity · security units

Gabelli Healthcare & WellnessRx Trust · Common Stock · Purchase (code P) · Non-derivative · Currency not specified

Reported transaction sizes by transaction dateEach point is one transaction for the selected company, security, and acquisition type. Reporting owners, exact quantities, and values are also provided in the table. These are filing amounts, not a stock-price series.11,3120Gabelli Healthcare & WellnessRx Trust · Saba Capital Management, L.P. (10% owner) · Purchase · December 16, 2025 · Quantity 11,312 · Price 9.37 · Reference value 105,993.44 · Currency not specifiedDec 16, 2025Dec 18, 2025No reported values to plot for this selection.

Swipe the chart to see the full date range. Exact records are available in the table below.

1 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

50 dated transactions in this page sample · 24 reporting owners.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition typeQuantityPriceReference valueCurrency
Dec 16, 2025Gabelli Healthcare & WellnessRx TrustCommon StockSaba Capital Management, L.P. (10% owner)Purchase11,3129.37105,993.44Currency not specified
Dec 17, 2025NEW GERMANY FUND INCCommon StockSaba Capital Management, L.P. (10% owner)Purchase4,39911.2549,488.75Currency not specified
Dec 16, 2025NEW GERMANY FUND INCCommon StockSaba Capital Management, L.P. (10% owner)Purchase9,64311.35109,448.05Currency not specified
Dec 16, 2025MEXICO FUND INCCommon StockSaba Capital Management, L.P. (10% owner)Purchase16,22819.95323,748.6Currency not specified
Dec 16, 2025EDISON INTERNATIONALRestricted Stock UnitsRigatti Maria C. (EXEC. VP AND CFO)Exercise / conversion82000Currency not specified
Dec 16, 2025EDISON INTERNATIONALCommon StockRigatti Maria C. (EXEC. VP AND CFO)Exercise / conversion820Not reportedNot reportedCurrency not specified
Dec 16, 2025ARROWHEAD PHARMACEUTICALS, INC.Common StockFerrari Mauro (Director)Stock award7,81900Currency not specified
Dec 18, 2025FRANKLIN FINANCIAL SERVICES CORP /PA/Common StockFisher Daniel J (Director)Stock award19655.3210,842.72Currency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsPrudo-Chlebosz Raymond (Director)Purchase386,6610.4041156,249.7101Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase ADRsPrudo-Chlebosz Raymond (Director)Purchase386,661Not reportedNot reportedCurrency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsPrudo-Chlebosz Raymond (Director)Purchase618,6580.4041249,999.6978Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Prudo-Chlebosz Raymond (Director)Purchase618,658Not reportedNot reportedCurrency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsPatel Sandip I (Director)Purchase154,6640.404162,499.7224Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase ADRsPatel Sandip I (Director)Purchase154,664Not reportedNot reportedCurrency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsPatel Sandip I (Director)Purchase247,4620.404199,999.3942Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Patel Sandip I (Director)Purchase247,462Not reportedNot reportedCurrency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsHuh Hoyoung (Director · 10% owner)Purchase3,093,2930.40411,249,999.7013Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase ADRsHuh Hoyoung (Director · 10% owner)Purchase3,093,293Not reportedNot reportedCurrency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsHuh Hoyoung (Director · 10% owner)Purchase618,6580.4041249,999.6978Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Huh Hoyoung (Director · 10% owner)Purchase618,658Not reportedNot reportedCurrency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsFarag Kameel D. (Interim CFO)Purchase24,7450.40419,999.4545Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Farag Kameel D. (Interim CFO)Purchase24,745Not reportedNot reportedCurrency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsPatel Samir Rashmikant (Director · 10% owner)Purchase231,9970.404193,749.9877Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase ADRsPatel Samir Rashmikant (Director · 10% owner)Purchase231,997Not reportedNot reportedCurrency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsPatel Samir Rashmikant (Director · 10% owner)Purchase618,6580.4041249,999.6978Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Patel Samir Rashmikant (Director · 10% owner)Purchase618,658Not reportedNot reportedCurrency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsGaslightwala Abizer (CEO · Director)Purchase773,3230.4041312,499.8243Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase ADRsGaslightwala Abizer (CEO · Director)Purchase773,323Not reportedNot reportedCurrency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsGaslightwala Abizer (CEO · Director)Purchase309,3280.4041124,999.4448Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Gaslightwala Abizer (CEO · Director)Purchase309,328Not reportedNot reportedCurrency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsBazemore Robert B (Director)Purchase30,9320.404112,499.6212Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase ADRsBazemore Robert B (Director)Purchase30,932Not reportedNot reportedCurrency not specified
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsBazemore Robert B (Director)Purchase123,7310.404149,999.6971Currency not specified
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Bazemore Robert B (Director)Purchase123,731Not reportedNot reportedCurrency not specified
Dec 16, 2025Nakamoto Inc.Common StockDalton John Merritt (Chief Accounting Officer)Stock award1,574,80300Currency not specified
Dec 16, 2025Nakamoto Inc.Common StockGendron Teresa S (Chief Financial Officer)Stock award2,624,67100Currency not specified
Dec 16, 2025CALLAN JMB INC.Common StockWilliams Wayne D (CEO, Chairman and President · Director · 10% owner)Purchase5,0001.738,650Currency not specified
Dec 18, 2025Prairie Operating Co.Common StockNarrogal Nominees Pty Ltd (10% owner) · Narrogal Nominees Pty Ltd ATF Gregory K O'Neill Family Trust (10% owner) · O'Neill Gregory K (10% owner)Purchase36,7011.6861,657.68Currency not specified
Dec 17, 2025Prairie Operating Co.Common StockNarrogal Nominees Pty Ltd (10% owner) · Narrogal Nominees Pty Ltd ATF Gregory K O'Neill Family Trust (10% owner) · O'Neill Gregory K (10% owner)Purchase20,7951.678734,908.5665Currency not specified
Dec 17, 2025Prairie Operating Co.Common StockNarrogal Nominees Pty Ltd (10% owner) · Narrogal Nominees Pty Ltd ATF Gregory K O'Neill Family Trust (10% owner) · O'Neill Gregory K (10% owner)Purchase50,0001.6884,000Currency not specified
Dec 16, 2025Prairie Operating Co.Common StockNarrogal Nominees Pty Ltd (10% owner) · Narrogal Nominees Pty Ltd ATF Gregory K O'Neill Family Trust (10% owner) · O'Neill Gregory K (10% owner)Purchase36,0221.67960,480.938Currency not specified
Dec 16, 2025Prairie Operating Co.Common StockNarrogal Nominees Pty Ltd (10% owner) · Narrogal Nominees Pty Ltd ATF Gregory K O'Neill Family Trust (10% owner) · O'Neill Gregory K (10% owner)Purchase50,0001.6884,000Currency not specified
Dec 16, 2025AMERICAN BATTERY TECHNOLOGY CoCommon StockWu Steven (Chief Operating Officer)Stock award38,47800Currency not specified
Dec 16, 2025AMERICAN BATTERY TECHNOLOGY CoCommon StockWu Steven (Chief Operating Officer)Stock award30,17700Currency not specified
Dec 17, 2025Silvia, Inc.Common Stock, par value $0.001Pompliano Anthony John III (Chief Executive Officer · Director · 10% owner)Purchase298,0003.371,004,260Currency not specified
Dec 17, 2025Duke Energy CORPDirector Savings Plan Restricted Stock Unit DeferralsKesner Idalene Fay (Director)Stock award287117.4333,702.41Currency not specified
Dec 16, 2025Rent the Runway, Inc.Class A Common StockROSENSWEIG DANIEL (Director)Stock award16,75900Currency not specified
Dec 16, 2025Rent the Runway, Inc.Class A Common StockBariquit Teri (Director)Stock award16,75900Currency not specified
Dec 16, 2025Rent the Runway, Inc.Restricted Stock UnitsTam Sarah K (Chief Merchant Officer)Stock award200,59800Currency not specified
Dec 16, 2025Rent the Runway, Inc.Restricted Stock UnitsSchembri Cara (Chief Legal & Admin. Officer)Stock award120,35900Currency not specified

Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transaction details

Reporting owners, quantities, prices, and source filings.

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Gabelli Healthcare & WellnessRx TrustGRX · company listingsPurchaseCommon StockNon-derivative security · Code P11,3129.37Value: 105,993.44Currency not specifiedView ↗
Trade: NEW GERMANY FUND INCGF · company listingsPurchaseCommon StockNon-derivative security · Code P4,39911.25Value: 49,488.75Currency not specifiedView ↗
Trade: NEW GERMANY FUND INCGF · company listingsPurchaseCommon StockNon-derivative security · Code P9,64311.35Value: 109,448.05Currency not specifiedView ↗
Trade: MEXICO FUND INCMXF · company listingsPurchaseCommon StockNon-derivative security · Code P16,22819.95Value: 323,748.6Currency not specifiedView ↗
Trade: EDISON INTERNATIONALEIX · company listings
Rigatti Maria C.EXEC. VP AND CFO
Exercise / conversionRestricted Stock UnitsDerivative security · Code M8200Value: 0Currency not specifiedView ↗
Trade: EDISON INTERNATIONALEIX · company listings
Rigatti Maria C.EXEC. VP AND CFO
Exercise / conversionCommon StockNon-derivative security · Code M820Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: ARROWHEAD PHARMACEUTICALS, INC.ARWR · company listingsStock awardCommon StockNon-derivative security · Code A7,8190Value: 0Currency not specifiedView ↗
Trade: FRANKLIN FINANCIAL SERVICES CORP /PA/FRAF · company listingsStock awardCommon StockNon-derivative security · Code A19655.32Value: 10,842.72Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P386,6610.4041 *Value: 156,249.7101Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase ADRsDerivative security · Code P386,661Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P618,6580.4041 *Value: 249,999.6978Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P618,658Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P154,6640.4041 *Value: 62,499.7224Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase ADRsDerivative security · Code P154,664Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P247,4620.4041 *Value: 99,999.3942Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P247,462Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Huh HoyoungDirector · 10% owner
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P3,093,2930.4041 *Value: 1,249,999.7013Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Huh HoyoungDirector · 10% owner
PurchaseWarrants to purchase ADRsDerivative security · Code P3,093,293Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Huh HoyoungDirector · 10% owner
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P618,6580.4041 *Value: 249,999.6978Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Huh HoyoungDirector · 10% owner
PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P618,658Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Farag Kameel D.Interim CFO
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P24,7450.4041 *Value: 9,999.4545Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Farag Kameel D.Interim CFO
PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P24,745Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Patel Samir RashmikantDirector · 10% owner
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P231,9970.4041 *Value: 93,749.9877Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Patel Samir RashmikantDirector · 10% owner
PurchaseWarrants to purchase ADRsDerivative security · Code P231,997Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Patel Samir RashmikantDirector · 10% owner
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P618,6580.4041 *Value: 249,999.6978Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Patel Samir RashmikantDirector · 10% owner
PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P618,658Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P773,3230.4041 *Value: 312,499.8243Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
PurchaseWarrants to purchase ADRsDerivative security · Code P773,323Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P309,3280.4041 *Value: 124,999.4448Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listings
Gaslightwala AbizerCEO · Director
PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P309,328Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P30,9320.4041 *Value: 12,499.6212Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase ADRsDerivative security · Code P30,932Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P123,7310.4041 *Value: 49,999.6971Currency not specifiedView ↗
Trade: Akari Therapeutics PlcAKTX · company listingsPurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P123,731Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Nakamoto Inc.NAKA · company listings
Dalton John MerrittChief Accounting Officer
Stock awardCommon StockNon-derivative security · Code A1,574,8030Value: 0Currency not specifiedView ↗
Trade: Nakamoto Inc.NAKA · company listings
Gendron Teresa SChief Financial Officer
Stock awardCommon StockNon-derivative security · Code A2,624,6710Value: 0Currency not specifiedView ↗
Trade: CALLAN JMB INC.CJMB · company listings
Williams Wayne DCEO, Chairman and President · Director · 10% owner
PurchaseCommon StockNon-derivative security · Code P5,0001.73Value: 8,650Currency not specifiedView ↗
Trade: Prairie Operating Co.PROP · company listingsJoint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P36,7011.68Value: 61,657.68Currency not specifiedView ↗
Trade: Prairie Operating Co.PROP · company listingsJoint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P20,7951.6787Value: 34,908.5665Currency not specifiedView ↗
Trade: Prairie Operating Co.PROP · company listingsJoint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P50,0001.68Value: 84,000Currency not specifiedView ↗
Trade: Prairie Operating Co.PROP · company listingsJoint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P36,0221.679Value: 60,480.938Currency not specifiedView ↗
Trade: Prairie Operating Co.PROP · company listingsJoint filing · amounts unallocatedPurchaseCommon StockNon-derivative security · Code P50,0001.68Value: 84,000Currency not specifiedView ↗
Trade: AMERICAN BATTERY TECHNOLOGY CoABAT · company listings
Wu StevenChief Operating Officer
Stock awardCommon StockNon-derivative security · Code A38,4780Value: 0Currency not specifiedView ↗
Trade: AMERICAN BATTERY TECHNOLOGY CoABAT · company listings
Wu StevenChief Operating Officer
Stock awardCommon StockNon-derivative security · Code A30,1770Value: 0Currency not specifiedView ↗
Trade: Silvia, Inc.SVIA · SVIAW · company listings
Pompliano Anthony John IIIChief Executive Officer · Director · 10% owner
PurchaseCommon Stock, par value $0.001Non-derivative security · Code P298,0003.37Value: 1,004,260Currency not specifiedView ↗
Trade: Duke Energy CORPDUK · DUKB · DUK-PA · DUKU · company listingsStock awardDirector Savings Plan Restricted Stock Unit DeferralsDerivative security · Code A287117.43Value: 33,702.41Currency not specifiedView ↗
Trade: Rent the Runway, Inc.RENT · company listingsStock awardClass A Common StockNon-derivative security · Code A16,7590Value: 0Currency not specifiedView ↗
Trade: Rent the Runway, Inc.RENT · company listingsStock awardClass A Common StockNon-derivative security · Code A16,7590Value: 0Currency not specifiedView ↗
Trade: Rent the Runway, Inc.RENT · company listings
Tam Sarah KChief Merchant Officer
Stock awardRestricted Stock UnitsDerivative security · Code A200,5980Value: 0Currency not specifiedView ↗
Trade: Rent the Runway, Inc.RENT · company listings
Schembri CaraChief Legal & Admin. Officer
Stock awardRestricted Stock UnitsDerivative security · Code A120,3590Value: 0Currency not specifiedView ↗

Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →